1 | 1 | | |
---|
2 | 2 | | |
---|
3 | 3 | | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. |
---|
4 | 4 | | [Brackets] indicate matter deleted from existing law. |
---|
5 | 5 | | *sb0476* |
---|
6 | 6 | | |
---|
7 | 7 | | SENATE BILL 476 |
---|
8 | 8 | | J5, J4 5lr1399 |
---|
9 | 9 | | CF 5lr1400 |
---|
10 | 10 | | By: Senator Beidle |
---|
11 | 11 | | Introduced and read first time: January 22, 2025 |
---|
12 | 12 | | Assigned to: Finance |
---|
13 | 13 | | |
---|
14 | 14 | | A BILL ENTITLED |
---|
15 | 15 | | |
---|
16 | 16 | | AN ACT concerning 1 |
---|
17 | 17 | | |
---|
18 | 18 | | Health Insurance – Genetic Testing and Cancer Imaging – Required Coverage 2 |
---|
19 | 19 | | and Prohibited Cost–Sharing 3 |
---|
20 | 20 | | |
---|
21 | 21 | | FOR the purpose of requiring certain insurers, nonprofit health service plans, and health 4 |
---|
22 | 22 | | maintenance organizations to provide coverage for genetic testing for certain 5 |
---|
23 | 23 | | individuals who may have an increased risk of developing cancer and follow–up 6 |
---|
24 | 24 | | evidence–based cancer imaging for individuals with an increased risk of developing 7 |
---|
25 | 25 | | cancer; prohibiting certain insurers, nonprofit health service plans, and health 8 |
---|
26 | 26 | | maintenance organizations from imposing a copayment, coinsurance, or deductible 9 |
---|
27 | 27 | | requirement on coverage for genetic testing and follow–up evidence–based cancer 10 |
---|
28 | 28 | | imaging; and generally relating to health insurance coverage for genetic testing and 11 |
---|
29 | 29 | | cancer imaging. 12 |
---|
30 | 30 | | |
---|
31 | 31 | | BY adding to 13 |
---|
32 | 32 | | Article – Insurance 14 |
---|
33 | 33 | | Section 15–861 15 |
---|
34 | 34 | | Annotated Code of Maryland 16 |
---|
35 | 35 | | (2017 Replacement Volume and 2024 Supplement) 17 |
---|
36 | 36 | | |
---|
37 | 37 | | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 18 |
---|
38 | 38 | | That the Laws of Maryland read as follows: 19 |
---|
39 | 39 | | |
---|
40 | 40 | | Article – Insurance 20 |
---|
41 | 41 | | |
---|
42 | 42 | | 15–861. 21 |
---|
43 | 43 | | |
---|
44 | 44 | | (A) THIS SECTION APPLIES TO: 22 |
---|
45 | 45 | | |
---|
46 | 46 | | (1) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 23 |
---|
47 | 47 | | PROVIDE HOSPITAL , MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GR OUPS 24 2 SENATE BILL 476 |
---|
48 | 48 | | |
---|
49 | 49 | | |
---|
50 | 50 | | ON AN EXPENSE –INCURRED BASIS UNDER HEALTH I NSURANCE POLICIES OR 1 |
---|
51 | 51 | | CONTRACTS THAT ARE I SSUED OR DELIVERED I N THE STATE; AND 2 |
---|
52 | 52 | | |
---|
53 | 53 | | (2) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 3 |
---|
54 | 54 | | HOSPITAL, MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GR OUPS UNDER 4 |
---|
55 | 55 | | CONTRACTS THAT ARE I SSUED OR DELIV ERED IN THE STATE. 5 |
---|
56 | 56 | | |
---|
57 | 57 | | (B) AN ENTITY SUBJECT TO THIS SECTION SHALL P ROVIDE COVERAGE FOR : 6 |
---|
58 | 58 | | |
---|
59 | 59 | | (1) GENETIC TESTING TO I DENTIFY WHETHER AN I NDIVIDUAL WITH A 7 |
---|
60 | 60 | | PERSONAL OR FAMILY H ISTORY OF CANCER HAS AN INHERITED MUTATIO N 8 |
---|
61 | 61 | | ASSOCIATED WITH AN I NCREASED RISK OF CAN CER IF THE GENETIC TES TING IS: 9 |
---|
62 | 62 | | |
---|
63 | 63 | | (I) RECOMMENDED BY A HEA LTH CARE PROFESSIONAL ; AND 10 |
---|
64 | 64 | | |
---|
65 | 65 | | (II) CONSISTENT WITH EVID ENCE–BASED, CLINICAL PRACTICE 11 |
---|
66 | 66 | | GUIDELINES; AND 12 |
---|
67 | 67 | | |
---|
68 | 68 | | (2) IF AN INDIVIDUAL WHO UNDERGOES GENETI C TESTING FOR 13 |
---|
69 | 69 | | WHICH COVERAGE IS PR OVIDED UNDER ITEM (1) OF THIS SUBSECTION IS 14 |
---|
70 | 70 | | DETERMINED TO BE AT AN INCREASED RISK O F DEVELOPING CANCER , FOLLOW–UP 15 |
---|
71 | 71 | | EVIDENCE–BASED CANCER IMAGING THAT: 16 |
---|
72 | 72 | | |
---|
73 | 73 | | (I) IS RECOMMENDED FOR T HE TYPE OF CANCER ID ENTIFIED 17 |
---|
74 | 74 | | BY THE GENETIC TESTI NG; AND 18 |
---|
75 | 75 | | |
---|
76 | 76 | | (II) USES MODALITIES ESTA BLISHED IN THE MOST RECENT 19 |
---|
77 | 77 | | VERSION OF THE NATIONAL COMPREHENSIVE CANCER NETWORK CLINICAL 20 |
---|
78 | 78 | | PRACTICE GUIDELINES IN ONCOLOGY. 21 |
---|
79 | 79 | | |
---|
80 | 80 | | (C) (1) EXCEPT AS PROVIDED IN PARAGRAPH (2) OF THIS SUBSECTION , 22 |
---|
81 | 81 | | AN ENTITY SUBJECT TO THIS SECTION MAY NOT IMPOSE A COPAYMENT , 23 |
---|
82 | 82 | | COINSURANCE , OR DEDUCTIBLE REQUIREME NT ON COVERAGE FOR GENETIC 24 |
---|
83 | 83 | | TESTING OR FOLLOW–UP EVIDENCE–BASED CANCER IMAGING AS DESCRIBED IN 25 |
---|
84 | 84 | | SUBSECTION (B) OF THIS SECTION. 26 |
---|
85 | 85 | | |
---|
86 | 86 | | (2) (I) IF THE APPLICATION OF T HE REQUIREMENTS UNDE R 27 |
---|
87 | 87 | | PARAGRAPH (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS 28 |
---|
88 | 88 | | ACCOUNT INELIGIBILIT Y UNDER 26 U.S.C. § 223, THE REQUIREMENT SHAL L APPLY 29 |
---|
89 | 89 | | TO THE HEALTH SAVINGS ACCOU NT–QUALIFIED HIGH DEDUC TIBLE HEALTH PLANS 30 |
---|
90 | 90 | | WITH RESPECT TO THE DEDUCTIB LE OF THE PLAN AFTER THE BENEFICIARY 31 |
---|
91 | 91 | | SATISFIES THE MINIMUM DEDUCTIBLE UNDER 26 U.S.C. § 223. 32 |
---|
92 | 92 | | SENATE BILL 476 3 |
---|
93 | 93 | | |
---|
94 | 94 | | |
---|
95 | 95 | | (II) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 1 |
---|
96 | 96 | | ACCORDANCE WITH 26 U.S.C. § 223(C)(2)(C), THE REQUIREMENTS OF THIS 2 |
---|
97 | 97 | | SUBSECTION SHALL APP LY REGARDLESS OF WHE THER THE BENEFICIARY STATUS 3 |
---|
98 | 98 | | SATISFIES THE MINIMUM DEDUCTIBLE U NDER 26 U.S.C. § 223. 4 |
---|
99 | 99 | | |
---|
100 | 100 | | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 5 |
---|
101 | 101 | | policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 6 |
---|
102 | 102 | | after January 1, 2026. 7 |
---|
103 | 103 | | |
---|
104 | 104 | | SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 8 |
---|
105 | 105 | | January 1, 2026. 9 |
---|